 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | Compound 451238 / Royal Marsden Hospital
Enrollment closed: Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma (clinicaltrials.gov) - Dec 15, 2021
P1/2, N=12, Active, not recruiting, Sponsor: Royal Marsden NHS Foundation Trust
Recruiting --> Active, not recruiting
- || Compound 451238 / Royal Marsden Hospital
Enrollment open, Trial completion date, Trial primary completion date: Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma (clinicaltrials.gov) - Jun 30, 2021
P1/2, N=12, Recruiting, Sponsor: Royal Marsden NHS Foundation Trust
Recruiting --> Active, not recruiting Active, not recruiting --> Recruiting | Trial completion date: Feb 2022 --> Jan 2023 | Trial primary completion date: Sep 2020 --> May 2022
- | Compound 451238 / Royal Marsden Hospital
Enrollment closed, Trial primary completion date: Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma (clinicaltrials.gov) - Apr 7, 2020
P1/2, N=12, Active, not recruiting, Sponsor: Royal Marsden NHS Foundation Trust
Active, not recruiting --> Recruiting | Trial completion date: Feb 2022 --> Jan 2023 | Trial primary completion date: Sep 2020 --> May 2022 Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2020 --> Sep 2020
- | Compound 451238 / Royal Marsden Hospital
Enrollment open: Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma (clinicaltrials.gov) - Jan 11, 2019
P1/2, N=12, Recruiting, Sponsor: Royal Marsden NHS Foundation Trust
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2020 --> Sep 2020 Not yet recruiting --> Recruiting
- | Compound 451238 / Royal Marsden Hospital
New P1/2 trial: Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma (clinicaltrials.gov) - Jul 26, 2018
P1/2, N=12, Not yet recruiting, Sponsor: Royal Marsden NHS Foundation Trust